Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saracatinib in Recurrent or Metastatic HNSCC
NCT00513435Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jul 2007
- Primary completion
- Mar 2011
- Countries
- 1
01
Overview
A Phase 2 trial of saracatinib in head and neck squamous cell carcinoma (HNSCC), sponsored by National Cancer Institute. Started Jul 2007; status: completed.
02
Drugs
saracatinib
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT00513435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00513435.